Drug · DIN 00535435
TEVA-ECTOSONE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since July 3, 2020; first marketed December 31, 1981.
- Drug Identification Number (DIN)
- 00535435
- Company (DIN owner)
- Teva Canada LimitedToronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Cream
- Route
- Topical
- Therapeutic class (ATC)
- Betamethasone D07AC01
- Class
- Human
- Record last updated
- July 8, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BETAMETHASONE (BETAMETHASONE VALERATE) | 0.1 % |
Recalls and safety alerts that mention it
Health Canada’s recall notices do not carry licence numbers, so these are matched by name: notices whose title or product names “teva-ectosone”. A notice may cover another product or only some lots: read it to see what it covers.
- TEVA-ECTOSONE 0.1% Cream; Affected lot may be missing lot number and expiry dateAugust 7, 2026 · Drugs · Labelling · Type II
- Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risksAugust 5, 2024 · Drugs · Product quality - Labelling · Type I
- Expanded recall: ratio-ECTOSONE (TEVA-ECTOSONE) 0.1% regular lotion and 0.05% mild lotion recalled due to an impurity that may pose health risksAugust 3, 2024 · Drugs · Product quality
- Teva-Ectosone: product qualityMarch 2, 2022 · Drugs · Product quality · Type III
Other DINs named TEVA-ECTOSONE
- DIN 00535427 · Marketed
- DIN 00653209 · Marketed
- DIN 00750050 · Marketed
- DIN 00653217 · Cancelled Post Market